Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms

Forman, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

van de Velde, 2009, Gastric cancer, Lancet, 374, 477, 10.1016/S0140-6736(09)60617-6

Kim, 2009, Is there a role for second-line chemotherapy in advanced gastric cancer?, Lancet Oncol, 10, 903, 10.1016/S1470-2045(09)70136-6

Chen, 2007, Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo, Cell Res, 17, 274, 10.1038/cr.2007.21

Eisenbrand, 1992, Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine, 817

Li, 1986, [Characteristics of the cytostatic effects of oridonin in vitro]. [Article in Chinese], Zhongguo Yao Li Xue Bao, 7, 361

Qu, 2014, Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S, Cancer Res, 74, 4409, 10.1158/0008-5472.CAN-13-1748

Zhang, 2011, Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin, Biomacromolecules, 12, 4335, 10.1021/bm201270m

Tian, 2012, Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line, Int J Nanomedicine, 7, 1793, 10.2147/IJN.S29483

Ikejima, 2009, Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells, Autophagy, 5, 430, 10.4161/auto.5.3.7896

Ikejima, 2007, Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation, J Pharmacol Sci, 105, 317, 10.1254/jphs.FP0070336

Olson, 2009, The many roles of histone deacetylases in development and physiology: implications for disease and therapy, Nat Rev Genet, 10, 32, 10.1038/nrg2485

Johnstone, 2014, Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders, Nat Rev Drug Discov, 13, 673, 10.1038/nrd4360

Zhao, 2014, Protein lysine acetylation guards metabolic homeostasis to fight against cancer, Oncogene, 33, 2279, 10.1038/onc.2013.163

Brown, 2012, Lysine acetylation in obesity, diabetes and metabolic disease, Immunol Cell Biol, 90, 39, 10.1038/icb.2011.99

Liu, 2014, Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature, Cancer Prev Res, 7

Oyelere, 2012, Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed, Future Med Chem, 4, 505, 10.4155/fmc.12.3

La Thangue, 2012, KDAC inhibitor-based therapies: can we interpret the code?, Mol Oncol, 6, 637, 10.1016/j.molonc.2012.09.003

Bae, 2011, Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs, Am J Transl Res, 3, 166

Alvarez, 2008, Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (KAT) inhibitory activities, ChemMedChem, 3, 1435, 10.1002/cmdc.200800096

Kwon, 2009, Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation, Cancer Res, 69, 583, 10.1158/0008-5472.CAN-08-2442

Tian, 2010, Inhibition of p300-HAT results in a reduced histone acetylation and down-regulation of gene expression in cardiac myocytes, Life Sci, 87, 707, 10.1016/j.lfs.2010.10.009

Varier, 2004, Polyisoprenylated benzophenone, garcinol, a natural KAT inhibitor represses chromatin transcription and alters global gene expression, J Biol Chem, 279, 33716, 10.1074/jbc.M402839200

Bártová, 2013, Basic nuclear processes affected by histone acetyltransferases and histone deacetylase inhibitors, Epigenomics, 5, 379, 10.2217/epi.13.38

Adams, 2014, Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy, Nat Rev Mol Cell Biol, 15, 49, 10.1038/nrm3722

Reed, 1998, Mitochondria and apoptosis, Science, 281, 1309, 10.1126/science.281.5381.1309

Gu, 2011, The impact of acetylation and deacetylation on the p53 pathway, Protein Cell, 2, 456, 10.1007/s13238-011-1063-9

Barton, 2012, p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells, PLoS Biol, 10, e1001268, 10.1371/journal.pbio.1001268

Roeder, 1997, Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain, Cell, 90, 595, 10.1016/S0092-8674(00)80521-8

Meisinger, 2014, Mitochondria. Cell cycle-dependent regulation of mitochondrial preprotein translocase, Science, 346, 1109, 10.1126/science.1261253

Solá, 2014, Tauroursodeoxycholic acid increases neural stem cell pool and neuronal conversion by regulating mitochondria-cell cycle retrograde signaling, Cell Cycle, 13, 3576, 10.4161/15384101.2014.962951

Shen, 2014, Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway, Tumour Biol, 35, 9139, 10.1007/s13277-014-2178-4

Diao, 2013, The novel human β-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss, J Biol Chem, 288, 12270, 10.1074/jbc.M112.411884

De Tommasi, 2013, Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells, J Proteomics, 82, 14, 10.1016/j.jprot.2013.01.030

Prendergast, 1997, The polyproline region of p53 is required to activate apoptosis but not growth arrest, Oncogene, 15, 887, 10.1038/sj.onc.1201263

Wang, 2013, Progastrin stimulates colonic cellproliferation via CCK2R- and β-arrestin-dependent suppression of BMP2, Gastroenterology, 145, e10